529 WEEK 12 HBSAG TITER DECLINE IS PREDICTIVE OF SVR IN CHRONIC HEPATITIS B PATIENTS RECEIVING PEGYLATED INTERFERON PLUS TENOFOVIR COMBINATION THERAPY

2012 ◽  
Vol 56 ◽  
pp. S209-S210 ◽  
Author(s):  
P. Marcellin ◽  
M. Martinot-Peignoux ◽  
M. Lapalus ◽  
O. Lada ◽  
Q. Zhang ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Combination Therapy ◽  
Chronic Hepatitis B ◽  
Pegylated Interferon ◽  
Hbsag Titer

Sustained antiviral effects and clearance of hepatitis surface antigen after combination therapy with entecavir and pegylated interferon in chronic hepatitis B

2018 ◽  
Vol 23 (6) ◽  
pp. 513-521 ◽  
Author(s):  
Satoru Hagiwara ◽  
Naoshi Nishida ◽  
Tomohiro Watanabe ◽  
Hiroshi Ida ◽  
Toshiharu Sakurai ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Combination Therapy ◽  
Chronic Hepatitis B ◽  
Surface Antigen ◽  
Pegylated Interferon ◽  
Antiviral Effects
Sign in / Sign up

Export Citation Format

Share Document